SUPERNUS PHARMACEUTICALS, INC. Payments to Acquire Property, Plant, and Equipment in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Payments to Acquire Property, Plant, and Equipment history and growth rate from 2010 to Q1 2025.
  • Supernus Pharmaceuticals, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending March 31, 2025 was $327K, a 31.9% increase year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $725K, a 31.6% increase from 2023.
  • Supernus Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $551K, a 33.7% increase from 2022.
  • Supernus Pharmaceuticals, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $412K.
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Growth (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Growth (%)

SUPERNUS PHARMACEUTICALS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $327K +$79K +31.9% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $248K -$30K -10.8% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 $278K -$573K -67.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $851K -$657K -43.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 $1.51M -$1.03M -40.6% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-07
Q1 2020 $2.54M +$2.32M +1048% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $221K -$32K -12.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q1 2018 $253K -$47K -15.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $300K +$21K +7.53% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $279K +$90K +47.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 $189K -$74K -28.1% Jan 1, 2015 Mar 31, 2015 10-Q/A 2017-01-20
Q1 2014 $263K -$109K -29.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 $372K +$332K +830% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q1 2012 $40K -$163K -80.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $203K Jan 1, 2011 Mar 31, 2011 10-Q 2012-06-08

SUPERNUS PHARMACEUTICALS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $725K +$174K +31.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-25
2023 $551K +$139K +33.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-25
2022 $412K Jan 1, 2022 Dec 31, 2022 10-K 2025-02-25
2020 $3.45M +$713K +26.1% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-08
2019 $2.74M +$1.89M +224% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-08
2018 $844K -$1.19M -58.4% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $2.03M +$426K +26.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $1.6M -$501K -23.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $2.1M +$1.51M +255% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $593K -$1.05M -64% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-16
2013 $1.65M +$893K +119% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $753K +$68K +9.93% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $685K +$391K +133% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 $294K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.